{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:00:21Z","timestamp":1789092021336,"version":"build-2803163510"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX003724"],"award-info":[{"award-number":["BX003724"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK099134"],"award-info":[{"award-number":["DK099134"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR077533"],"award-info":[{"award-number":["AR077533"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Endocrine and Metabolic Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.coemr.2022.100433","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T20:28:12Z","timestamp":1671568092000},"page":"100433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Endocrine functions of sclerostin"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7265-6939","authenticated-orcid":false,"given":"Ryan C.","family":"Riddle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coemr.2022.100433_bib1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine regulation of energy metabolism by the skeleton","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.coemr.2022.100433_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41574-019-0246-y","article-title":"The role of osteoblasts in energy homeostasis","volume":"15","author":"Dirckx","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.coemr.2022.100433_bib3","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.bone.2011.04.012","article-title":"Relationship between abdominal fat and bone mineral density in white and African American adults","volume":"50","author":"Katzmarzyk","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.coemr.2022.100433_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S2213-8587(21)00347-8","article-title":"Bone fragility in diabetes: novel concepts and clinical implications","volume":"10","author":"Hofbauer","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.coemr.2022.100433_bib5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cell.2010.06.002","article-title":"Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition","volume":"142","author":"Fulzele","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.coemr.2022.100433_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cmet.2013.04.009","article-title":"Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1","volume":"17","author":"Kajimura","year":"2013","journal-title":"Cell Metabol"},{"key":"10.1016\/j.coemr.2022.100433_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(00)81558-5","article-title":"Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass","volume":"100","author":"Ducy","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.coemr.2022.100433_bib8","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature10763","article-title":"The contribution of bone to whole-organism physiology","volume":"481","author":"Karsenty","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.coemr.2022.100433_bib9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coemr.2022.100433_bib10","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coemr.2022.100433_bib11","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/dc14-2989","article-title":"Sclerostin and insulin resistance in prediabetes: evidence of a cross talk between bone and glucose metabolism","volume":"38","author":"Daniele","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.coemr.2022.100433_bib12","doi-asserted-by":"crossref","first-page":"E1473","DOI":"10.1210\/jc.2012-1218","article-title":"Association of circulating sclerostin levels with fat mass and metabolic disease--related markers in Japanese postmenopausal women","volume":"97","author":"Urano","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coemr.2022.100433_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00223-010-9372-1","article-title":"Sclerostin: current knowledge and future perspectives","volume":"87","author":"Moester","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.coemr.2022.100433_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/00016925509170789","article-title":"An uncommon familial systemic disease of the skeleton: hyperostosis corticalis generalisata familiaris","volume":"44","author":"Van Buchem","year":"1955","journal-title":"Acta Radiol"},{"key":"10.1016\/j.coemr.2022.100433_bib15","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1210\/jc.2005-1235","article-title":"Bone mineral density in sclerosteosis; affected individuals and gene carriers","volume":"90","author":"Gardner","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coemr.2022.100433_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.7326\/0003-4819-84-4-393","article-title":"The clinical features of sclerosteosis. A review of the manifestations in twenty-five affected individuals","volume":"84","author":"Beighton","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.coemr.2022.100433_bib17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/hmg\/10.5.537","article-title":"Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)","volume":"10","author":"Balemans","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coemr.2022.100433_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","article-title":"Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease","volume":"39","author":"Balemans","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.coemr.2022.100433_bib19","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.10401","article-title":"A\u00a052-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population","volume":"110","author":"Staehling-Hampton","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.coemr.2022.100433_bib20","doi-asserted-by":"crossref","first-page":"10890","DOI":"10.1074\/jbc.M807994200","article-title":"Characterization of the structural features and interactions of sclerostin: molecular insight into a key regulator of Wnt-mediated bone formation","volume":"284","author":"Veverka","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coemr.2022.100433_bib21","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.coemr.2022.100433_bib22","doi-asserted-by":"crossref","first-page":"14092","DOI":"10.1073\/pnas.1207188109","article-title":"Targeted deletion of Sost distal enhancer increases bone formation and bone mass","volume":"109","author":"Collette","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coemr.2022.100433_bib23","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.coemr.2022.100433_bib24","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/jbmr.14","article-title":"Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength","volume":"25","author":"Ominsky","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.coemr.2022.100433_bib25","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1359\/jbmr.090403","article-title":"A\u00a0short treatment with an antibody to sclerostin can inhibit bone loss in an ongoing model of colitis","volume":"24","author":"Eddleston","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.coemr.2022.100433_bib26","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1002\/jbmr.135","article-title":"Sclerostin antibody treatment enhances metaphyseal bone healing in rats","volume":"25","author":"Agholme","year":"2010","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.coemr.2022.100433_bib27","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/pro.2485","article-title":"The DAN family: modulators of TGF-beta signaling and beyond","volume":"23","author":"Nolan","year":"2014","journal-title":"Protein Sci"},{"key":"10.1016\/j.coemr.2022.100433_bib28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.coemr.2022.100433_bib29","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.coemr.2022.100433_bib30","doi-asserted-by":"crossref","first-page":"36293","DOI":"10.1074\/jbc.M400521200","article-title":"Noggin and sclerostin bone morphogenetic protein antagonists form a mutually inhibitory complex","volume":"279","author":"Winkler","year":"2004","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coemr.2022.100433_bib31","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bone.2013.02.022","article-title":"Regulation of Wnt\/beta-catenin signaling within and from osteocytes","volume":"54","author":"Burgers","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.coemr.2022.100433_bib32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bbrc.2009.01.062","article-title":"NMR structure of the Wnt modulator protein Sclerostin","volume":"380","author":"Weidauer","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coemr.2022.100433_bib33","doi-asserted-by":"crossref","first-page":"26464","DOI":"10.1074\/jbc.M112.350108","article-title":"Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors","volume":"287","author":"Holdsworth","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coemr.2022.100433_bib34","doi-asserted-by":"crossref","first-page":"19883","DOI":"10.1074\/jbc.M413274200","article-title":"Sclerostin binds to LRP5\/6 and antagonizes canonical Wnt signaling","volume":"280","author":"Li","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coemr.2022.100433_bib35","doi-asserted-by":"crossref","first-page":"26770","DOI":"10.1074\/jbc.M504308200","article-title":"SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor","volume":"280","author":"Semenov","year":"2005","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coemr.2022.100433_bib36","doi-asserted-by":"crossref","first-page":"38276","DOI":"10.1074\/jbc.M609509200","article-title":"LRP5 mutations linked to high bone mass diseases cause reduced LRP5 binding and inhibition by SOST","volume":"281","author":"Semenov","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coemr.2022.100433_bib37","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1359\/jbmr.060810","article-title":"Bone density ligand, Sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity","volume":"21","author":"Ellies","year":"2006","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.coemr.2022.100433_bib38","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature756","article-title":"Kremen proteins are Dickkopf receptors that regulate Wnt\/beta-catenin signalling","volume":"417","author":"Mao","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.coemr.2022.100433_bib39","doi-asserted-by":"crossref","first-page":"19489","DOI":"10.1074\/jbc.M110.190330","article-title":"Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function","volume":"286","author":"Leupin","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coemr.2022.100433_bib40","doi-asserted-by":"crossref","first-page":"E5187","DOI":"10.1073\/pnas.1413828111","article-title":"Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels","volume":"111","author":"Chang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coemr.2022.100433_bib41","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1073\/pnas.1419714112","article-title":"Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption","volume":"112","author":"Xiong","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coemr.2022.100433_bib42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/bonekey.2013.95","article-title":"Clinical utility of serum sclerostin measurements","volume":"2","author":"Clarke","year":"2013","journal-title":"BoneKEy Rep"},{"key":"10.1016\/j.coemr.2022.100433_bib43","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2011-3419","article-title":"Serum sclerostin and risk of hip fracture in older Caucasian women","volume":"97","author":"Arasu","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coemr.2022.100433_bib44","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1002\/jbmr.1718","article-title":"High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study","volume":"27","author":"Ardawi","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.coemr.2022.100433_bib45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jbmr.128","article-title":"Regulation of circulating sclerostin levels by sex steroids in women and in men","volume":"26","author":"Modder","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.coemr.2022.100433_bib46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.217","article-title":"Relation of age, gender, and bone mass to circulating sclerostin levels in women and men","volume":"26","author":"Modder","year":"2011","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.coemr.2022.100433_bib47","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/jc.2011-2186","article-title":"Circulating levels of sclerostin are increased in patients with type 2 diabetes mellitus","volume":"97","author":"Garcia-Martin","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coemr.2022.100433_bib48","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1210\/jc.2012-1901","article-title":"Sclerostin levels associated with inhibition of the Wnt\/beta-catenin signaling and reduced bone turnover in type 2 diabetes mellitus","volume":"97","author":"Gaudio","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coemr.2022.100433_bib49","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1210\/jc.2011-2958","article-title":"Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes","volume":"97","author":"Gennari","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coemr.2022.100433_bib50","article-title":"An insight into the association of sclerostin with insulin sensitivity and glycemic parameters in male Indian prediabetic and diabetic population","volume":"14","author":"Singh","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.coemr.2022.100433_bib51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/EJE-14-0106","article-title":"Gender differences in sclerostin and clinical characteristics in type 1 diabetes mellitus","volume":"171","author":"Catalano","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.coemr.2022.100433_bib52","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/cen.12364","article-title":"Clinical and endocrine correlates of circulating sclerostin levels in patients with type 1 diabetes mellitus","volume":"80","author":"Neumann","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.coemr.2022.100433_bib53","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s00198-014-2988-7","article-title":"Volumetric femoral BMD, bone geometry, and serum sclerostin levels differ between type 2 diabetic postmenopausal women with and without fragility fractures","volume":"26","author":"Heilmeier","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.coemr.2022.100433_bib54","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1210\/jc.2013-2143","article-title":"Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus","volume":"98","author":"Yamamoto","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coemr.2022.100433_bib55","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2011-2152","article-title":"Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults","volume":"97","author":"Amrein","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coemr.2022.100433_bib56","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2265.2011.04315.x","article-title":"Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women","volume":"76","author":"Sheng","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.coemr.2022.100433_bib57","doi-asserted-by":"crossref","first-page":"E2584","DOI":"10.1210\/jc.2013-4493","article-title":"Circulating sclerostin associated with vertebral bone marrow fat in older men but not women","volume":"99","author":"Ma","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.coemr.2022.100433_bib58","article-title":"Glycemic control and bone turnover in older Mexican Americans with type 2 diabetes","volume":"2018","author":"Rianon","year":"2018","journal-title":"J\u00a0Osteoporos"},{"key":"10.1016\/j.coemr.2022.100433_bib59","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/cen.13300","article-title":"The association between sclerostin and incident type 2 diabetes risk: a cohort study","volume":"86","author":"Yu","year":"2017","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.coemr.2022.100433_bib60","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00198-016-3540-8","article-title":"Has sclerostin a true endocrine metabolic action complementary to osteocalcin in older men?","volume":"27","author":"Confavreux","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.coemr.2022.100433_bib61","series-title":"Association between non-alcoholic fatty liver disease and bone turnover biomarkers in post-menopausal women with type 2 diabetes","author":"Mantovani","year":"2018"},{"key":"10.1016\/j.coemr.2022.100433_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52224-3","article-title":"Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetes","volume":"9","author":"Pacicca","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.coemr.2022.100433_bib63","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/jcp.24487","article-title":"TNF-alpha upregulates sclerostin expression in obese mice fed a high-fat diet","volume":"229","author":"Baek","year":"2014","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.coemr.2022.100433_bib64","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41413-021-00159-9","article-title":"Osteoblastic glucocorticoid signaling exacerbates high-fat-diet- induced bone loss and obesity","volume":"9","author":"Kim","year":"2021","journal-title":"Bone Res"},{"key":"10.1016\/j.coemr.2022.100433_bib65","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.lfs.2013.01.001","article-title":"Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST\/sclerostin in osteocytes","volume":"92","author":"Kim","year":"2013","journal-title":"Life Sci"},{"key":"10.1016\/j.coemr.2022.100433_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.944323","article-title":"Linagliptin in combination with metformin ameliorates diabetic osteoporosis through modulating BMP-2 and sclerostin in the high-fat diet fed C57BL\/6 mice","volume":"13","author":"Nirwan","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.coemr.2022.100433_bib67","doi-asserted-by":"crossref","first-page":"E11238","DOI":"10.1073\/pnas.1707876115","article-title":"Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes","volume":"114","author":"Kim","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coemr.2022.100433_bib68","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jbmr.3001","article-title":"Osteocyte-secreted Wnt signaling inhibitor sclerostin contributes to beige adipogenesis in peripheral fat depots","volume":"32","author":"Fulzele","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.coemr.2022.100433_bib69","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ydbio.2013.08.015","article-title":"Sost and its paralog Sostdc1 coordinate digit number in a Gli3-dependent manner","volume":"383","author":"Collette","year":"2013","journal-title":"Dev Biol"},{"key":"10.1016\/j.coemr.2022.100433_bib70","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/dvdy.21054","article-title":"SOST expression is restricted to the great arteries during embryonic and neonatal cardiovascular development","volume":"236","author":"van Bezooijen","year":"2007","journal-title":"Dev Dynam"},{"key":"10.1016\/j.coemr.2022.100433_bib71","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/jbmr.3467","article-title":"Conditional deletion of Sost in MSC-derived lineages identifies specific cell-type contributions to bone mass and B-cell development","volume":"33","author":"Yee","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.coemr.2022.100433_bib72","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100691R","article-title":"Bone-derived sclerostin and Wnt\/beta-catenin signaling regulate PDGFRalpha(+) adipoprogenitor cell differentiation","volume":"35","author":"Kim","year":"2021","journal-title":"Faseb J"},{"key":"10.1016\/j.coemr.2022.100433_bib73","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1074\/jbc.RA118.006769","article-title":"Lrp4 expression by adipocytes and osteoblasts differentially impacts sclerostin's endocrine effects on body composition and glucose metabolism","volume":"294","author":"Kim","year":"2019","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coemr.2022.100433_bib74","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/jcp.25976","article-title":"The skeletal cell-derived molecule sclerostin drives bone marrow adipogenesis","volume":"233","author":"Fairfield","year":"2018","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.coemr.2022.100433_bib75","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American heart association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"}],"container-title":["Current Opinion in Endocrine and Metabolic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451965022001181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451965022001181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:54:14Z","timestamp":1762527254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451965022001181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":75,"alternative-id":["S2451965022001181"],"URL":"https:\/\/doi.org\/10.1016\/j.coemr.2022.100433","relation":{},"ISSN":["2451-9650"],"issn-type":[{"value":"2451-9650","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine functions of sclerostin","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Endocrine and Metabolic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coemr.2022.100433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100433"}}